Last reviewed · How we verify
Marrow stromal cell infusion
At a glance
| Generic name | Marrow stromal cell infusion |
|---|---|
| Also known as | Gene marking, mesenchymal cells |
| Sponsor | St. Jude Children's Research Hospital |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Dizziness, headache
- Fluid Overload, Dehydration
- Venous Pressure Jugular Increased
- Muscle Spasms
- Alanine aminotransferase increased
- Anemia
- Aspartate aminotransferase increased
- Hyponatremia
- Platelet count decreased
- Blood bilirubin increased
- Hypermagnesemia
- Hypoalbuminemia
Key clinical trials
- Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease (PHASE1)
- Tolerance by Engaging Antigen During Cellular Homeostasis (PHASE1)
- Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT (PHASE1)
- Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines (PHASE1)
- Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI) (PHASE1, PHASE2)
- Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma (PHASE1)
- Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Marrow stromal cell infusion CI brief — competitive landscape report
- Marrow stromal cell infusion updates RSS · CI watch RSS
- St. Jude Children's Research Hospital portfolio CI